GALT
Galectin Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.61
+5.98%0
Insider buys (3m)
6
Insider sells (3m)
-$509.8K
Net value (3m)
+95.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Uihlein Richard E · director, 10 percent owner: | M-Exempt | 2,550,932 | $4.05 |
| Aug 4, 2026 | Uihlein Richard E · director, 10 percent owner: | M-Exempt | 31,825,235 | $3.00 |
| Aug 4, 2026 | Uihlein Richard E · director, 10 percent owner: | M-Exempt | 0 | $3.00 |
| Jul 16, 2026 | Jamil Khurram · officer: Chief Medical Officer | Sale | 16,250 | $5.13 |
| Jul 16, 2026 | Jamil Khurram · officer: Chief Medical Officer | M-Exempt | 16,250 | $3.04 |
| Jun 30, 2026 | Jamil Khurram · officer: Chief Medical Officer | M-Exempt | 47,467 | $2.50 |
| Jun 30, 2026 | Shlevin Harold H. · director | M-Exempt | 22,268 | $1.23 |
| Jun 30, 2026 | Jamil Khurram · officer: Chief Medical Officer | Sale | 2,533 | $5.00 |
| Jun 30, 2026 | Jamil Khurram · officer: Chief Medical Officer | M-Exempt | 2,037 | $2.20 |
| Jun 30, 2026 | Shlevin Harold H. · director | Sale | 22,268 | $5.04 |
| Jun 30, 2026 | Jamil Khurram · officer: Chief Medical Officer | M-Exempt | 2,533 | $2.50 |
| Jun 30, 2026 | Shlevin Harold H. · director | Sale | 7,732 | $5.00 |
| Jun 30, 2026 | Jamil Khurram · officer: Chief Medical Officer | Sale | 47,467 | $5.04 |
| Jun 30, 2026 | Shlevin Harold H. · director | M-Exempt | 7,732 | $1.23 |
| Jun 25, 2026 | Jamil Khurram · officer: Chief Medical Officer | M-Exempt | 7,557 | $1.23 |
| Jun 25, 2026 | Jamil Khurram · officer: Chief Medical Officer | Sale | 7,557 | $3.14 |
| May 28, 2026 | Jamil Khurram · officer: Chief Medical Officer | Sale | 568 | $3.10 |
| May 28, 2026 | Jamil Khurram · officer: Chief Medical Officer | M-Exempt | 568 | $1.23 |
| Feb 9, 2026 | ELDRED KARY · director | Purchase | 300 | $2.70 |
| Jan 22, 2026 | LEWIS JOEL · director, officer: President and CEO | A-Award | 91,000 | $3.04 |
| Jan 21, 2026 | AMELIO GILBERT F · director | A-Award | 60,000 | $3.04 |
| Jan 21, 2026 | FREEMAN KEVIN D · director | A-Award | 60,000 | $3.04 |
| Jan 21, 2026 | OMENN GILBERT S · director | A-Award | 60,000 | $0.00 |
| Jan 21, 2026 | Shlevin Harold H. · director | A-Award | 60,000 | $3.04 |
| Jan 21, 2026 | CALLICUTT JACK W · officer: Chief Financial Officer | A-Award | 65,000 | $3.04 |
| Jan 21, 2026 | Jamil Khurram · officer: Chief Medical Officer | A-Award | 65,000 | $3.04 |
| Jan 21, 2026 | CALLICUTT JACK W · officer: Chief Financial Officer | A-Award | 100,000 | $0.00 |
| Jan 21, 2026 | Jamil Khurram · officer: Chief Medical Officer | A-Award | 100,000 | $0.00 |
| Jan 21, 2026 | CARSON BENJAMIN SR · director | A-Award | 60,000 | $3.04 |
| Jan 21, 2026 | LEWIS JOEL · director, officer: President and CEO | A-Award | 84,000 | $3.04 |
Institutional positioning
13F filings over the trailing two quarters
New 40Increased 66Reduced 48Sold out 19
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 2,988,353 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,168,065 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,966,542 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,308,394 | Aug 12, 2026 |
| MARSHALL WACE, LLP | Increased | 1,219,912 | May 15, 2026 |
| OSAIC HOLDINGS, INC. | Increased | 1,203,725 | Aug 14, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Increased | 1,122,670 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1,073,202 | May 15, 2026 |
| MARSHALL WACE, LLP | Reduced | 831,010 | Aug 13, 2026 |
| GREAT POINT PARTNERS LLC | Unchanged | 800,000 | Aug 14, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 800,000 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 799,237 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 798,434 | May 15, 2026 |
| Wealthspire Advisors, LLC | Unchanged | 721,788 | Aug 11, 2026 |
| WEALTHSPIRE ADVISORS, LLC | Increased | 721,788 | May 1, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 4, 2026